Browsing by Author Bourantas, K. L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 96  next >
TitleAuthor(s)Issue date
A 54-year-old stockbreeder with ascitesBourantas, K. L.; Christou, L. G.; Dalekos, G. N.; Barbati, K.; Tsianos, E. V.24-Nov-2015
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasmsHatzimichael, E.; Dasoula, A.; Benetatos, L.; Makis, A.; Stebbing, J.; Crook, T.; Syrrou, M.; Bourantas, K. L.24-Nov-2015
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasiaHatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L.24-Nov-2015
Acute lymphoblastic leukaemia presenting as an enlarged goitre in a pregnant woman with Graves' diseaseTsabouri, S. E.; Tsatsoulis, A.; Giannoutsos, C.; Bourantas, K. L.24-Nov-2015
Acute phase proteins and interleukins in steady state sickle cell diseaseBourantas, K. L.; Dalekos, G. N.; Makis, A.; Chaidos, A.; Tsiara, S.; Mavridis, A.24-Nov-2015
Administration of a modified chemotherapeutic regimen containing vincristine, liposomal doxorubicin and dexamethasone to multiple myeloma patients: preliminary dataTsiara, S. N.; Kapsali, E.; Christou, L.; Panteli, A.; Pritsivelis, N.; Bourantas, K. L.24-Nov-2015
Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patientsMakis, A. C.; Hatzimichael, E. C.; Mavridis, A.; Bourantas, K. L.24-Nov-2015
Antierythropoietin antibodies in thalassemia patientsVoulgari, P. V.; Chaidos, A.; Tzouvara, E.; Alymara, V.; Alamanos, Y.; Drosos, A. A.; Bourantas, K. L.24-Nov-2015
Atypical presentation of post-partum visceral LeishmaniasisMilionis, H. J.; Bourantas, K. L.; Bai, M.; Elisaf, M. S.24-Nov-2015
Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin diseaseVassou, A.; Alymara, V.; Chaidos, A.; Bourantas, K. L.24-Nov-2015
Bloodstream infections in adult patients with malignant blood disorders and neutropenia: Microbial spectrum and antimicrobial susceptibility patternLevidiotou, S.; Bouranta, P.; Gartzonika, C.; Papamichail, D.; Bourantas, K. L.24-Nov-2015
Brucellosis-induced autoimmune hemolytic anemia treated with rituximabBourantas, L. K.; Pappas, G.; Kapsali, E.; Gougopoulou, D.; Papamichail, D.; Bourantas, K. L.24-Nov-2015
C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell diseaseMakis, A. C.; Hatzimichael, E. C.; Stebbing, J.; Bourantas, K. L.24-Nov-2015
Childhood brucellosis in north-western Greece: a retrospective analysisGalanakis, E.; Bourantas, K. L.; Leveidiotou, S.; Lapatsanis, P. D.24-Nov-2015
Chronic myelogenous leukemia terminating in acute megakaryoblastic leukemia. Case reportBourantas, K. L.; Repousis, P.; Tsiara, S.; Christou, L.; Konstantinidou, P.; Bai, M.24-Nov-2015
Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatmentMakis, A. C.; Hatzimichael, E. C.; Kolios, G.; Bourantas, K. L.24-Nov-2015
Clinical correlation of bone marrow microvessel density in essential thrombocythemiaPanteli, K.; Zagorianakou, N.; Agnantis, N. J.; Bourantas, K. L.; Bai, M.24-Nov-2015
Coexistence of myelodysplastic syndrome and multiple myelomaTsiara, S.; Economou, G.; Panteli, A.; Isaakidis, P.; Kapsali, E.; Bourantas, K. L.24-Nov-2015
Combination therapy with interferon alfa-2b and hydroxyurea during the accelerated phase of chronic myelogenous leukemiaBourantas, K. L.; Syrou, M.; Tsiara, S.; Danella, M.; Konstantinides, P.24-Nov-2015
Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosisBourantas, K. L.; Tsiara, S.; Christou, L.; Repousis, P.; Konstantinidou, P.; Bai, M.; Seferiadis, K.24-Nov-2015